Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Neogen Corporation

NEOGNASDAQ
Healthcare
Medical - Diagnostics & Research
$9.09
$-0.26(-2.78%)
U.S. Market opens in 13h 13m

Neogen Corporation Fundamental Analysis

Neogen Corporation (NEOG) shows weak financial fundamentals with a PE ratio of -3.24, profit margin of -68.47%, and ROE of -26.92%. The company generates $0.9B in annual revenue with weak year-over-year growth of -3.20%.

Key Strengths

PEG Ratio-0.08
Current Ratio3.91

Areas of Concern

ROE-26.92%
Operating Margin-1.96%
We analyze NEOG's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -55.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-55.1/100

We analyze NEOG's fundamental strength across five key dimensions:

Efficiency Score

Weak

NEOG struggles to generate sufficient returns from assets.

ROA > 10%
-17.94%

Valuation Score

Excellent

NEOG trades at attractive valuation levels.

PE < 25
-3.24
PEG Ratio < 2
-0.08

Growth Score

Weak

NEOG faces weak or negative growth trends.

Revenue Growth > 5%
-3.20%
EPS Growth > 10%
-114.63%

Financial Health Score

Excellent

NEOG maintains a strong and stable balance sheet.

Debt/Equity < 1
0.38
Current Ratio > 1
3.91

Profitability Score

Weak

NEOG struggles to sustain strong margins.

ROE > 15%
-2692.38%
Net Margin ≥ 15%
-68.47%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is NEOG Expensive or Cheap?

P/E Ratio

NEOG trades at -3.24 times earnings. This suggests potential undervaluation.

-3.24

PEG Ratio

When adjusting for growth, NEOG's PEG of -0.08 indicates potential undervaluation.

-0.08

Price to Book

The market values Neogen Corporation at 0.93 times its book value. This may indicate undervaluation.

0.93

EV/EBITDA

Enterprise value stands at -3.01 times EBITDA. This is generally considered low.

-3.01

How Well Does NEOG Make Money?

Net Profit Margin

For every $100 in sales, Neogen Corporation keeps $-68.47 as profit after all expenses.

-68.47%

Operating Margin

Core operations generate -1.96 in profit for every $100 in revenue, before interest and taxes.

-1.96%

ROE

Management delivers $-26.92 in profit for every $100 of shareholder equity.

-26.92%

ROA

Neogen Corporation generates $-17.94 in profit for every $100 in assets, demonstrating efficient asset deployment.

-17.94%

Following the Money - Real Cash Generation

Operating Cash Flow

Neogen Corporation generates limited operating cash flow of $66.24M, signaling weaker underlying cash strength.

$66.24M

Free Cash Flow

Neogen Corporation generates weak or negative free cash flow of $17.21M, restricting financial flexibility.

$17.21M

FCF Per Share

Each share generates $0.08 in free cash annually.

$0.08

FCF Yield

NEOG converts 0.87% of its market value into free cash.

0.87%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-3.24

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.08

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.93

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.22

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.38

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.91

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.27

vs 25 benchmark

ROA

Return on assets percentage

-0.18

vs 25 benchmark

ROCE

Return on capital employed

-0.01

vs 25 benchmark

How NEOG Stacks Against Its Sector Peers

MetricNEOG ValueSector AveragePerformance
P/E Ratio-3.2428.25 Better (Cheaper)
ROE-26.92%780.00% Weak
Net Margin-68.47%-20122.00% (disorted) Weak
Debt/Equity0.380.30 Weak (High Leverage)
Current Ratio3.914.66 Strong Liquidity
ROA-17.94%-14687.00% (disorted) Weak

NEOG outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Neogen Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

3.67%

Industry Style: Defensive, Growth, Innovation

Growing

EPS CAGR

-989.73%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-68.28%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ